BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 31865802)

  • 1. JAK inhibition in the treatment of alopecia areata - a promising new dawn?
    Ismail FF; Sinclair R
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):43-51. PubMed ID: 31865802
    [No Abstract]   [Full Text] [Related]  

  • 2. The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature.
    Crowley EL; Fine SC; Katipunan KK; Gooderham MJ
    J Cutan Med Surg; 2019; 23(3):289-297. PubMed ID: 30688081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs for alopecia areata: JAK inhibitors.
    Iorizzo M; Tosti A
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):77-81. PubMed ID: 29466675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of janus kinase inhibitors in the treatment of alopecia areata.
    Triyangkulsri K; Suchonwanit P
    Drug Des Devel Ther; 2018; 12():2323-2335. PubMed ID: 30100707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis.
    Wei D; Chen Y; Shen Y; Xie B; Song X
    Front Immunol; 2023; 14():1152513. PubMed ID: 37138884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel investigational drugs for alopecia areata and future perspectives.
    Chim I; Ghiya R; Sinclair RD; Eisman S
    Expert Opin Investig Drugs; 2024 May; 33(5):441-449. PubMed ID: 38682280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Janus kinase inhibitors for alopecia areata.
    King BA; Craiglow BG
    J Am Acad Dermatol; 2023 Aug; 89(2S):S29-S32. PubMed ID: 37591562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinase inhibitors for alopecia areata: A narrative review.
    Haughton RD; Herbert SM; Ji-Xu A; Downing L; Raychaudhuri SP; Maverakis E
    Indian J Dermatol Venereol Leprol; 2023; 89(6):799-806. PubMed ID: 37436019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs under investigation for the treatment of alopecias.
    Ocampo-Garza J; Griggs J; Tosti A
    Expert Opin Investig Drugs; 2019 Mar; 28(3):275-284. PubMed ID: 30642204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Janus kinase inhibitors: An innovative treatment for alopecia areata.
    Park H; Yu DA; Kwon O
    J Dermatol; 2019 Aug; 46(8):724-730. PubMed ID: 31237712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review.
    de Oliveira AB; Alpalhão M; Filipe P; Maia-Silva J
    Dermatol Ther; 2019 Sep; 32(5):e13053. PubMed ID: 31381252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ritlecitinib: an investigational drug for the treatment of moderate to severe alopecia areata.
    Eisman S; Sinclair R
    Expert Opin Investig Drugs; 2021 Dec; 30(12):1169-1174. PubMed ID: 34826225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
    Ramot Y; Zlotogorski A
    Harefuah; 2020 Jan; 159(1):38-42. PubMed ID: 31930807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.
    Lensing M; Jabbari A
    Front Immunol; 2022; 13():955035. PubMed ID: 36110853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.
    Jabbari A; Sansaricq F; Cerise J; Chen JC; Bitterman A; Ulerio G; Borbon J; Clynes R; Christiano AM; Mackay-Wiggan J
    J Invest Dermatol; 2018 Jul; 138(7):1539-1545. PubMed ID: 29452121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK inhibitors for alopecia areata: a systematic review and meta-analysis.
    Phan K; Sebaratnam DF
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):850-856. PubMed ID: 30762909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata.
    Dillon KL
    Clin Cosmet Investig Dermatol; 2021; 14():691-714. PubMed ID: 34211288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baricitinib for the Treatment of Alopecia Areata.
    Freitas E; Guttman-Yassky E; Torres T
    Drugs; 2023 Jun; 83(9):761-770. PubMed ID: 37195491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and Emerging Therapies for Alopecia Areata.
    Pourang A; Mesinkovska NA
    Drugs; 2020 May; 80(7):635-646. PubMed ID: 32323220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.